BridgeMD
Intubation Conditions in Morbidly Obese Patients with Rapid Sequence Induction: A Comparative Study of Rocuronium Dosing based on Ideal vs. Real Body Weight
EU CTIS ID: 2025-520977-37-00
What this study is testing
The main objective is to compare the intubation conditions in morbidly obese patients (BMI ≥ 40 kg/m²) when using a rocuronium dose based on ideal body weight versus real body weight
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Adult patients >= 18 years.
- BMI ≥ 40 kg/m²
- Scheduled for elective surgery requiring endotracheal intubation
You likely can't join if
- Known allergies for rocuronium bromide and/or the bromide ion.
- Use of medications known to interfere with neuromuscular function
- History of neuromuscular disorders
- Pregnancy
- Impaired hepatic or renal function
- Non-elective procedures
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.